An alternate-day corticosteroid regimen in maintenance therapy of giant cell arteritis

Acta Med Scand. 1981;209(5):347-50. doi: 10.1111/j.0954-6820.1981.tb11605.x.

Abstract

It is well established that the side-effects of corticosteroid treatment can be reduced by administering the steroid on alternate days. Twenty-seven patients with giant cell arteritis were given daily treatment initially, followed by a gradual transition to alternate-day treatment. It was possible to maintain 18 (67%) of 27 patients on this regimen. In 9 (33%) the regimen was abandoned because of clinical symptoms on the "day off". These patient, however, could be maintained with a single morning dose of the corticosteroid. Morning plasma cortisol levels on the treatment day were normal in all patients treated with 20 mg prednisolone or less every other day.

MeSH terms

  • Female
  • Giant Cell Arteritis / drug therapy*
  • Humans
  • Male
  • Polymyalgia Rheumatica / drug therapy*
  • Prednisolone / administration & dosage
  • Prednisolone / therapeutic use*
  • Time Factors

Substances

  • Prednisolone